COMMUNIQUÉS West-GlobeNewswire

GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT
15/05/2024
1-for-5 reverse stock split to become effective as of the opening of trading on May 20, 2024 Rutherford, NJ, May 15, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical [...]
CooperCompanies to Participate in the Jefferies Global Healthcare Conference
15/05/2024
SAN RAMON, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024. [...]
Plus Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
15/05/2024
Announced private placement of up to $19.25M with healthcare funds and insiders Received $3M award recommendation from the Department of Defense to support Plus’ clinical brain cancer program Acquired synergistic [...]
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
15/05/2024
Conference call and webcast scheduled on May 22, 2024, at 8:00 am EDT / 2:00 pm CEST PARIS and CAMBRIDGE, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the ‘‘ Company ’’), a late- [...]
NANOBIOTIX publiera ses résultats financiers et opérationnels du premier trimestre 2024 le 22 mai 2024
15/05/2024
Conférence téléphonique et diffusion en direct sur Internet le 22 mai 2024 à 14 h 00 CEST / 8 h 00 EDT PARIS et CAMBRIDGE, Mass., 15 mai 2024 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext : NANO –– NASDAQ : NBTX – la « [...]
INVO Reports Record First Quarter 2024 Financial Results
15/05/2024
353% Revenue Growth with improvement in Adjusted EBITDA SARASOTA, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on [...]
Panbela Provides Business Update and Reports Q1 2024 Financial Results
15/05/2024
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today [...]
Agile Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
15/05/2024
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- [...]
Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update
15/05/2024
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected in 2H 2024 Enrollment ongoing in PIVOT-PO, a pivotal Phase 3 [...]
Merit Medical Executive Leadership Team Update
15/05/2024
Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports “Continued Growth Initiatives” Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI [...]
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
15/05/2024
HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative [...]
Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15/05/2024
Dosing of all patients in clinical trial of BT-600 has been successfully completed, with results anticipated in late Q2 2024 Clinical data on device function of the NaviCap™ platform to be presented at DDW on May 19 [...]
Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates
15/05/2024
Topline data from Phase 2/3 LIFT-AD clinical trial of fosgonimeton as a potential treatment for mild-to-moderate Alzheimer’s disease expected in second half of 2024 Submitted Investigational New Drug application to U.S [...]
Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
15/05/2024
Combination and monotherapy solid tumor dose escalation data for CLN-619 to be presented in a poster session at ASCO 2024 Annual Meeting CLN-978 development to focus exclusively on autoimmune diseases, starting with [...]
OrthoPediatrics Corp. Continued Leading Sponsorship at 2024 EPOSNA Annual Meeting
15/05/2024
Reinforced Long-Term Commitment as Emerald Sponsor WARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of [...]
Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
15/05/2024
Patient enrollment underway in sunRIZE global Phase 3 clinical study of RZ358 in patients with congenital hyperinsulinism (cHI); topline results expected in mid-2025 Completed in-vivo toxicology study in brown Norway [...]
Oncocyte Reports First Quarter 2024 Financial Results
15/05/2024
Conference Call on Wednesday, May 15, 2024 at 1:30 p.m. PT / 4:30 p.m. ET IRVINE, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today reported financial [...]
Inotiv Reports Second Quarter Financial Results for Fiscal 2024 and Provides Business Update
15/05/2024
— Second quarter fiscal 2024 revenue down 21.5% to $119.0 million — Year-to-date fiscal 2024 revenue down 7.2% to $254.5 million — Agreement in principle reached with the U.S. Department of Justice on related matter — [...]
AB Science reports its revenues for the year 2023 and provides an update on its activities
15/05/2024
PRESS RELEASE AB SCIENCE PRESENTS ITS FINANCIAL INFORMATION AS OF DECEMBER 31, 2023 AND THE KEY EVENTS OF THE PERIOD Clinical development Continuation of the conditional marketing authorisation application procedures [...]

Pages